A Vision for Personalized Medicine
Genomics pioneer Leroy Hood says a coming revolution in medicine will bring enormous new opportunities.
By Emily Singer
Why: By reducing the cost of diagnostic tests, it has allowed the monitoring of more disease markers.
Key innovation: Its synthetic antibodies replace more expensive antibodies widely used in diagnostics.
Headquarters: Seattle
Founded: 2009
Funding Raised: $30 million
Last updated: 02/22/2012
Please let Technology Review know if you have updates for this Company Profile here.